Login / Signup
NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?
John R Ingram
T Burton
Published in:
The British journal of dermatology (2017)
Keyphrases
</>
hidradenitis suppurativa
high intensity
small molecule
early onset
rheumatoid arthritis
systemic lupus erythematosus
disease activity
ulcerative colitis